Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS)

ABSTRACT Transthyretin amyloidosis (ATTR) is characterized by the deposit of mutant or wild-type transthyretin that forms amyloid fibrils, which are extracellularly deposited within tissues and organs. Clinical manifestations of familial amyloid polyneuropathy vary according to the mutation, age at...

Full description

Saved in:
Bibliographic Details
Main Authors: Márcia Waddington Cruz, Marcus Vinicius Pinto, Luiz Felipe Pinto, Renata Gervais, Moisés Dias, Carlos Perez, Rajiv Mundayat, Moh-Lim Ong, Roberto Coury Pedrosa, Débora Foguel
Format: Article
Language:English
Published: Thieme Revinter Publicações
Series:Arquivos de Neuro-Psiquiatria
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2019000200096&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850185675984338944
author Márcia Waddington Cruz
Marcus Vinicius Pinto
Luiz Felipe Pinto
Renata Gervais
Moisés Dias
Carlos Perez
Rajiv Mundayat
Moh-Lim Ong
Roberto Coury Pedrosa
Débora Foguel
author_facet Márcia Waddington Cruz
Marcus Vinicius Pinto
Luiz Felipe Pinto
Renata Gervais
Moisés Dias
Carlos Perez
Rajiv Mundayat
Moh-Lim Ong
Roberto Coury Pedrosa
Débora Foguel
author_sort Márcia Waddington Cruz
collection DOAJ
description ABSTRACT Transthyretin amyloidosis (ATTR) is characterized by the deposit of mutant or wild-type transthyretin that forms amyloid fibrils, which are extracellularly deposited within tissues and organs. Clinical manifestations of familial amyloid polyneuropathy vary according to the mutation, age at onset and geographical location. This study aimed to describe baseline disease characteristics of Brazilian patients with transthyretin familial amyloid polyneuropathy (ATTR-FAP) enrolled in the Transthyretin Amyloidosis Outcome Survey (THAOS). Methods: The THAOS is an international, noninterventional, longitudinal, observational, web-based registry designed to characterize ATTR. The outcome measures included demographics (age at symptom onset, gender, time from onset of symptoms to diagnosis, family history), genotype, and clinical characteristics (presence of amyloid deposit, frequency of misdiagnosis, presenting symptomatology). The analysis was conducted in a dataset from Brazilian patients (from November 2008 to January 2016). Results: One hundred and sixty participants (52.5% male) were included in the analysis. The majority of participants (90.6%) reported a positive family history of ATTR-FAP Median age at symptom onset was 32.5 years. Val30Met mutation was found in 91.9%. Misdiagnosis was observed in 26.6% of symptomatic patients. Over one-third (35.3%) of the misdiagnosed patients experienced a delay of more than one year before receiving a correct diagnosis. At presentation, 79.7% of the patients had motor, 87.5% sensory and 93.8% autonomic symptoms. Conclusion: ATTR-FAP in Brazil starts early, has a strong family history and the majority has Val30Met mutation. Misdiagnosis is common and the most common presentation is of a sensorimotor and autonomic neuropathy.
format Article
id doaj-art-3cad4dfa144444e488dbf76795a0c821
institution OA Journals
issn 1678-4227
language English
publisher Thieme Revinter Publicações
record_format Article
series Arquivos de Neuro-Psiquiatria
spelling doaj-art-3cad4dfa144444e488dbf76795a0c8212025-08-20T02:16:38ZengThieme Revinter PublicaçõesArquivos de Neuro-Psiquiatria1678-42277729610010.1590/0004-282x20180156S0004-282X2019000200096Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS)Márcia Waddington CruzMarcus Vinicius PintoLuiz Felipe PintoRenata GervaisMoisés DiasCarlos PerezRajiv MundayatMoh-Lim OngRoberto Coury PedrosaDébora FoguelABSTRACT Transthyretin amyloidosis (ATTR) is characterized by the deposit of mutant or wild-type transthyretin that forms amyloid fibrils, which are extracellularly deposited within tissues and organs. Clinical manifestations of familial amyloid polyneuropathy vary according to the mutation, age at onset and geographical location. This study aimed to describe baseline disease characteristics of Brazilian patients with transthyretin familial amyloid polyneuropathy (ATTR-FAP) enrolled in the Transthyretin Amyloidosis Outcome Survey (THAOS). Methods: The THAOS is an international, noninterventional, longitudinal, observational, web-based registry designed to characterize ATTR. The outcome measures included demographics (age at symptom onset, gender, time from onset of symptoms to diagnosis, family history), genotype, and clinical characteristics (presence of amyloid deposit, frequency of misdiagnosis, presenting symptomatology). The analysis was conducted in a dataset from Brazilian patients (from November 2008 to January 2016). Results: One hundred and sixty participants (52.5% male) were included in the analysis. The majority of participants (90.6%) reported a positive family history of ATTR-FAP Median age at symptom onset was 32.5 years. Val30Met mutation was found in 91.9%. Misdiagnosis was observed in 26.6% of symptomatic patients. Over one-third (35.3%) of the misdiagnosed patients experienced a delay of more than one year before receiving a correct diagnosis. At presentation, 79.7% of the patients had motor, 87.5% sensory and 93.8% autonomic symptoms. Conclusion: ATTR-FAP in Brazil starts early, has a strong family history and the majority has Val30Met mutation. Misdiagnosis is common and the most common presentation is of a sensorimotor and autonomic neuropathy.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2019000200096&lng=en&tlng=enAmyloidosisamyloid neuropathies, familialpolyneuropathy
spellingShingle Márcia Waddington Cruz
Marcus Vinicius Pinto
Luiz Felipe Pinto
Renata Gervais
Moisés Dias
Carlos Perez
Rajiv Mundayat
Moh-Lim Ong
Roberto Coury Pedrosa
Débora Foguel
Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS)
Arquivos de Neuro-Psiquiatria
Amyloidosis
amyloid neuropathies, familial
polyneuropathy
title Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS)
title_full Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS)
title_fullStr Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS)
title_full_unstemmed Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS)
title_short Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS)
title_sort baseline disease characteristics in brazilian patients enrolled in transthyretin amyloidosis outcome survey thaos
topic Amyloidosis
amyloid neuropathies, familial
polyneuropathy
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2019000200096&lng=en&tlng=en
work_keys_str_mv AT marciawaddingtoncruz baselinediseasecharacteristicsinbrazilianpatientsenrolledintransthyretinamyloidosisoutcomesurveythaos
AT marcusviniciuspinto baselinediseasecharacteristicsinbrazilianpatientsenrolledintransthyretinamyloidosisoutcomesurveythaos
AT luizfelipepinto baselinediseasecharacteristicsinbrazilianpatientsenrolledintransthyretinamyloidosisoutcomesurveythaos
AT renatagervais baselinediseasecharacteristicsinbrazilianpatientsenrolledintransthyretinamyloidosisoutcomesurveythaos
AT moisesdias baselinediseasecharacteristicsinbrazilianpatientsenrolledintransthyretinamyloidosisoutcomesurveythaos
AT carlosperez baselinediseasecharacteristicsinbrazilianpatientsenrolledintransthyretinamyloidosisoutcomesurveythaos
AT rajivmundayat baselinediseasecharacteristicsinbrazilianpatientsenrolledintransthyretinamyloidosisoutcomesurveythaos
AT mohlimong baselinediseasecharacteristicsinbrazilianpatientsenrolledintransthyretinamyloidosisoutcomesurveythaos
AT robertocourypedrosa baselinediseasecharacteristicsinbrazilianpatientsenrolledintransthyretinamyloidosisoutcomesurveythaos
AT deborafoguel baselinediseasecharacteristicsinbrazilianpatientsenrolledintransthyretinamyloidosisoutcomesurveythaos